Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098174 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of MP-3180 in Healthy Volunteers
A Phase 1 study, sponsored by MediBeacon.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT02098174 is a Phase 1 study that has completed, run by MediBeacon. The registered enrollment target is 16 participants.
The verdict
NCT02098174, a Phase 1 study, has completed, sponsored by MediBeacon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study was to investigate the pharmacokinetics of MP-3180 (1 µmol/kg) compared to the pharmacokinetics of iohexol (5 mL of a 300 mg iodine (I)/mL solution) in healthy adult participants. The secondary objective was to evaluate the safety and tolerability of MP-3180 in healthy adult participants.
Interventions
- DRUG MP-3180
- OTHER Iohexol comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02098174
The ClinicalTrials.gov registry entry for NCT02098174 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MediBeacon, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MP-3180 is the first listed.
NCT02098174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02098174 about?
NCT02098174 is a clinical study titled "Pharmacokinetics of MP-3180 in Healthy Volunteers". The purpose of this study was to investigate the pharmacokinetics of MP-3180 (1 µmol/kg) compared to the pharmacokinetics of iohexol (5 mL of a 300 mg iodine (I)/mL solution) in healthy adult participants. The secondary objective was to evaluate the safety and tolerability of MP-3180 in healthy adul...
What is the current status of trial NCT02098174?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2013-11. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02098174?
The interventions under investigation include: MP-3180 (DRUG), Iohexol comparator (OTHER).
Who is sponsoring clinical trial NCT02098174?
This trial is sponsored by MediBeacon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.